The tests could prove useful in screening patients that coud benefit from therapies being tested for Alzheimer's. But uptake will depend, in part, on reimbursement, according to doctors surveyed by Quest.
Eddie Peloke, CEO of Workpath, spoke to why in-home care can drive the next stage of this industry-wide movement
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
In a Q&A, Truvian Sciences CEO Jeff Hawkins and Dena Marrinucci, founder and SVP Corporate Development and Business Operations talk about their point-of care blood testing technology.
The criminal trial of Theranos CEO Elizabeth Holmes will help entrepreneurs see the legal ramifications of hyping and under-delivering presumed medical advances and ultimately be good for innovation.
The diagnostics company has cut back most of its staff from more than 100 employees to about two dozen in the wake of a civil fraud complaint from the SEC last month, according to The Wall Street Journal.
Did Theranos intentionally mislead its board members or did the non-scientific group keep themselves in the dark? Either way, lessons abound for startups looking to fill advisory positions.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!